Last Update 20:47
Monday, 14 June 2021

US FDA approves Regeneron's drug as first treatment for Ebola virus

Reuters , Wednesday 14 Oct 2020
Share/Bookmark
Share/Bookmark

The US Food and Drug Administration on Wednesday approved Regeneron Pharmaceuticals' Inmazeb as the first FDA-approved treatment for the Ebola virus infection in adults and children.

Inmazeb, a mixture of three monoclonal antibodies, was tested in 382 adults and children with confirmed Zaire ebolavirus infection in a clinical trial, the health regulator said. 

Short link:

 

Latest

© 2010 Ahram Online.